Amlodipine besylate and Atorvastatin calcium

Product NDC: 59762-6710
Requested package NDC: 59762-6710-1
11-digit product format: 597626710
Labeler code: 59762
Product ID: 59762-6710_2c4cedeb-fc3c-4ba0-a899-19701dddc1d2
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: amlodipine besylate and atorvastatin calcium
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Greenstone LLC
Application: NDA021540
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2014-04-04
Marketing end: 0000-00-00
Substance: AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE
Active strength: 3 mg/1; mg/1
Pharmacologic classes: Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	59762-6710	59762-6710-1	D	Discontinued by firm		2026-08-03

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 11 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021540-001	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 5MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-01-30
N021540-002	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 5MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-01-30
N021540-003	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 5MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-01-30
N021540-004	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 5MG BASE;EQ 80MG BASE	TABLET / ORAL	AB	RLD	2004-01-30
N021540-005	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 10MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-01-30
N021540-006	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 10MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-01-30
N021540-007	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 10MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-01-30
N021540-008	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 10MG BASE;EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2004-01-30
N021540-009	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 2.5MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-07-29
N021540-010	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 2.5MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-07-29
N021540-011	CADUET	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM	EQ 2.5MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-07-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 11 matching rows.

Application-product, TE code table
Application-product	TE code
N021540-001	AB
N021540-002	AB
N021540-003	AB
N021540-004	AB
N021540-005	AB
N021540-006	AB
N021540-007	AB
N021540-008	AB
N021540-009	AB
N021540-010	AB
N021540-011	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 12 · 451 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021540-001	CADUET	EQ 5MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-002	CADUET	EQ 5MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-003	CADUET	EQ 5MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-004	CADUET	EQ 5MG BASE;EQ 80MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-005	CADUET	EQ 10MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-006	CADUET	EQ 10MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-007	CADUET	EQ 10MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-008	CADUET	EQ 10MG BASE;EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2004-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-009	CADUET	EQ 2.5MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-07-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-010	CADUET	EQ 2.5MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-07-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-011	CADUET	EQ 2.5MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-07-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-001	CADUET	EQ 5MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-002	CADUET	EQ 5MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-003	CADUET	EQ 5MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-004	CADUET	EQ 5MG BASE;EQ 80MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-005	CADUET	EQ 10MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-006	CADUET	EQ 10MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-007	CADUET	EQ 10MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-008	CADUET	EQ 10MG BASE;EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2004-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-009	CADUET	EQ 2.5MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-07-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-010	CADUET	EQ 2.5MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-07-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-011	CADUET	EQ 2.5MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-07-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021540-001	CADUET	EQ 5MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-002	CADUET	EQ 5MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-003	CADUET	EQ 5MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-004	CADUET	EQ 5MG BASE;EQ 80MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-005	CADUET	EQ 10MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-006	CADUET	EQ 10MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-007	CADUET	EQ 10MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-008	CADUET	EQ 10MG BASE;EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2004-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-009	CADUET	EQ 2.5MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-07-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-010	CADUET	EQ 2.5MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-07-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-011	CADUET	EQ 2.5MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-07-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-001	CADUET	EQ 5MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-002	CADUET	EQ 5MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-003	CADUET	EQ 5MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-004	CADUET	EQ 5MG BASE;EQ 80MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-005	CADUET	EQ 10MG BASE;EQ 10MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-006	CADUET	EQ 10MG BASE;EQ 20MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-007	CADUET	EQ 10MG BASE;EQ 40MG BASE	TABLET / ORAL	AB	RLD	2004-01-30	`fd3edfee7708…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 12 · 451 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021540-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-005	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-006	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-007	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-008	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-009	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-010	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021540-011	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-005	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-006	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-007	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-008	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-009	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-010	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021540-011	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021540-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-005	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-006	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-007	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-008	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-009	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-010	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021540-011	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-005	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-006	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021540-007	AB	1	`fd3edfee7708…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Caduet	AMLODIPINE AND ATORVASTATIN	Pfizer Laboratories Div Pfizer Inc	6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6	2026-06-25	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021540 application number: NDA021540
Caduet	AMLODIPINE AND ATORVASTATIN	Viatris Specialty LLC	164394b3-d7ba-4bbf-b64b-e2dd15735ea8	2026-06-25	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021540 application number: NDA021540
Amlodipine and Atorvastatin	AMLODIPINE AND ATORVASTATIN	Prasco Laboratories	14124e56-77ba-426d-8f5a-dbe42eda1a20	2026-05-21	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021540 application number: NDA021540

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59762-6710-1	EA - Each	59762-6710	bf6d6e56-b3b9-4d6c-914f-c6d445bdaf6b	1	2014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
AMLODIPINE BESYLATE	ACTIVE INGREDIENT	864V2Q084H	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
ATORVASTATIN CALCIUM TRIHYDRATE	ACTIVE INGREDIENT	48A5M73Z4Q	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
AMLODIPINE	ACTIVE MOIETY	1J444QC288	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
ATORVASTATIN	ACTIVE MOIETY	A0JWA85V8F	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
CALCIUM CARBONATE	INACTIVE INGREDIENT	H0G9379FGK	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
POLYETHYLENE GLYCOL 3000	INACTIVE INGREDIENT	SA1B764746	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10
WATER	INACTIVE INGREDIENT	059QF0KO0R	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	10

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
864V2Q084H	AMLODIPINE BESYLATE	111470-99-6	AMLODIPINE BESYLATE
48A5M73Z4Q	ATORVASTATIN CALCIUM TRIHYDRATE	344423-98-9	ATORVASTATIN CALCIUM TRIHYDRATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
59762-6710-1	59762671001	30 TABLET, FILM COATED in 1 BOTTLE (59762-6710-1)	2014-04-04	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Amlodipine besylate and Atorvastatin calcium	Greenstone LLC \| Pfizer Inc \| Pharmacia & Upjohn Company LLC \| Pfizer Ireland Pharmaceuticals \| Pfizer Manufacturing Deutschland GmbH	2023-10-31	HUMAN PRESCRIPTION DRUG LABEL	26